Sintx Technologies Inc - Utang kumulatif perusahaan SINT

Sintx Technologies (SINT) owns a state-of-the-art facility in Utah, controlling the production of silicon nitride ceramics. The company's US plants produce antibacterial materials for aviation and joint prosthetics. The company's debt financing reflects liability dynamics, where the parameter value equals 0.00. Rising demand for ultra-durable implants and the expansion of B2B partnerships with global medtech behemoths create a positive growth trajectory.

For Sintx Technologies (SINT), the debt burden dynamics reflect a balance between funding clinical trials and maintaining financial independence amid stable demand for medtech. This indicator aggregates all current and long-term liabilities in real-time, allowing investors to assess the speed of loan refinancing and the degree of capital resilience to macroeconomic pressure.